deca durabolin 25 mg/ml solution for injection
nv organon - nandrolone decanoate - solution for injection - 25 mg/ml
deca durabolin 50 mg/ml solution for injection
nv organon - nandrolone decanoate - solution for injection - 50 mg/ml
deca durabolin 25 mg / ml solution for injection ( 25 mg/ml solution for injection
organon laboratories limited - nandrolone decanoate - solution for injection - 25 mg/ml
deca durabolin 50 mg/ml solution for injection (am 50 mg/ml solution for injection
organon laboratories limited - nandrolone decanoate - solution for injection - 50 mg/ml
deca durabolin 100mg/ml, solution for injection (a
organon laboratories limited - nandrolone decanoate - solution for injection - 100 mg/ml
deca durabolin 100mg/ml, solution for injection (a 100 mg/ml solution for injection
organon laboratories limited - nandrolone decanoate - solution for injection - 100 mg/ml
deca durabolin 50 injection
nuvista pharma ltd - nandrolone - injection - 50 mg/ml
ridaura tablets
amdipharm mercury australia pty ltd - auranofin, quantity: 3 mg - tablet, film coated - excipient ingredients: titanium dioxide; maize starch; lactose monohydrate; magnesium stearate; iron oxide yellow; microcrystalline cellulose; hypromellose; purified water; sodium starch glycollate; propylene glycol; ethanol - indications as at 14 november 2000: adjunctive treatment of active classical or definite rheumatoid arthritis in adults who have an insufficient therapeutic response to, or are intolerant of, an adequate trial of a baseline therapeutic program, including among other measures, full doses of one or more non-steroidal anti-inflammatory drugs. ridaura is not indicated in non-rheumatoid arthropathies such as osteoarthrosis. ridaura should be added to a comprehensive baseline therapeutic program.
ridaura capsule
xediton pharmaceuticals inc - auranofin - capsule - 3mg - auranofin 3mg - gold compounds
geforcef 1g powder for injection
suhitas pharmaceuticals inc. - cefpirome sulfate - powder for injection - 1g